Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer
Abstract To determine the prognostic value of the timing of circulating breast tumour cell measurement during treatment, peripheral blood from 164 patients with breast disease was collected. Circulating tumour cells (CTCs) were enriched by using immunomagnetic nanospheres (IMNs) and were identified...
Guardado en:
Autores principales: | Shuyun Pang, Hanjun Li, Shu Xu, Liying Feng, Xueping Ma, Yanan Chu, Bingjie Zou, Shaohua Wang, Guohua Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb6c969eb23542aba07c636a853962c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
por: Pierre Pinochet, et al.
Publicado: (2021) -
Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer
por: Yan-jun Lu, et al.
Publicado: (2017) -
Prognostic value of baseline carotid blood flow in critically ill children with septic shock.
por: Fatma Mamdouh, et al.
Publicado: (2021) -
Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
por: Markéta Hudečková, et al.
Publicado: (2021) -
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
por: Min Zhang, et al.
Publicado: (2021)